These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20332095)

  • 1. Dose de-escalation strategies and role of therapeutic drug monitoring of biologics in RA.
    den Broeder AA; van der Maas A; van den Bemt BJ
    Rheumatology (Oxford); 2010 Oct; 49(10):1801-3. PubMed ID: 20332095
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of early rheumatoid arthritis in developing countries. Biologics or disease-modifying anti-rheumatic drugs?
    Yen JH
    Biomed Pharmacother; 2006 Dec; 60(10):688-92. PubMed ID: 17049202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biologicals are the first choice for RA treatment -- contra].
    Krüger K
    Dtsch Med Wochenschr; 2005 Aug; 130(33):1901. PubMed ID: 16118737
    [No Abstract]   [Full Text] [Related]  

  • 4. [Levamisole used in rheumatoid arthritis].
    Veys EM; Mielants H
    Acta Rhumatol; 1979; 3(3):219-30. PubMed ID: 11496645
    [No Abstract]   [Full Text] [Related]  

  • 5. [Perspective of ultrasound-guided strategy to reduce/discontinue biologics].
    Ikeda K; Iwamoto T; Nakajima H
    Nihon Rinsho; 2016 Jun; 74(6):919-23. PubMed ID: 27311179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rheumatoid arthritis: milestones in classification and treatment].
    Fiehn C
    Dtsch Med Wochenschr; 2011 Feb; 136(5):203-5. PubMed ID: 21271482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment and management of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should aggressive therapy for rheumatoid arthritis require early use of weekly low-dose methotrexate, as the first disease-modifying anti-rheumatic drug in most patients?
    Pincus T; Sokka T
    Rheumatology (Oxford); 2006 May; 45(5):497-9. PubMed ID: 16537578
    [No Abstract]   [Full Text] [Related]  

  • 9. Dose escalation of leflunomide (LEF) to 40 mg once daily in patients with rheumatoid arthritis and insufficient response to standard dose LEF.
    Fiehn C; Rochel E; Ho AD; Max R
    Ann Rheum Dis; 2004 Jun; 63(6):746-7. PubMed ID: 15140787
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rheumatoid arthritis: early aggressive therapy including biologicals -- pro].
    Rubbert-Roth A
    Dtsch Med Wochenschr; 2005 Aug; 130(33):1900. PubMed ID: 16118736
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment reduction in well-controlled rheumatoid arthritis. State of knowledge].
    Krüger K; Edelmann E
    Z Rheumatol; 2015 Jun; 74(5):414-20. PubMed ID: 26085073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtherapeutic dosing of methotrexate in rheumatoid arthritis trials.
    Parker CT; Mewshaw E; Dennis GJ
    J Am Osteopath Assoc; 2004 Jan; 104(1):7-8. PubMed ID: 14992316
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative overview of safety of the biologics in rheumatoid arthritis.
    Khraishi M
    J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Making smart investment decisions in clinical research.
    Bansback N; Keystone E; O'Dell J; Phibbs CS; Hannagan K; Brophy M; Anis A
    Trials; 2015 Dec; 16():590. PubMed ID: 26712327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lefunomide in combination therapy.
    Kalden JR; Smolen JS; Emery P; van Riel PL; Dougados M; Strand CV; Breedveld FC
    J Rheumatol Suppl; 2004 Jun; 71():25-30. PubMed ID: 15170905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding role of biologic agents in rheumatoid arthritis.
    Kalden JR
    J Rheumatol Suppl; 2002 Nov; 66():27-37. PubMed ID: 12435166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Termination of disease-modifying antirheumatic drugs in rheumatoid arthritis and in psoriatic arthritis. A comparative study of 270 cases.
    Ujfalussy I; Koó E; Seszták M; Gergely P
    Z Rheumatol; 2003 Apr; 62(2):155-60. PubMed ID: 12721703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab for rheumatoid arthritis.
    Palylyk-Colwell E; McGahan L
    Issues Emerg Health Technol; 2006 Sep; (89):1-4. PubMed ID: 17014062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targets for rheumatoid arthritis.
    Keystone EC; Haraoui B
    J Rheumatol Suppl; 2009 Jun; 82():1. PubMed ID: 19509323
    [No Abstract]   [Full Text] [Related]  

  • 20. How to dose infliximab in rheumatoid arthritis: new data on a serious issue.
    van Vollenhoven RF
    Ann Rheum Dis; 2009 Aug; 68(8):1237-9. PubMed ID: 19605741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.